to full maturation. Hence, understanding the factors, signals, or even the environment that induce MSCs towards specific chondrogenic lineage development and subsequent maintenance of the cartilage phenotype is necessary prior to clinical application. Recent work done by our group [16] , together with work by other groups [17, 18] , suggest possible combined effects of TGFβ1 and BMP2 in chondrogenic differentiation of MSCs that result in hyaline-like cartilage formation, with minimal progression to hypertrophy.
An alternative cell source for cartilage repair, other than primary explanted chondrocytes and BM-MSC, are human embryonic stem cells (hESCs) and stem cell lines derived from the inner cell mass of blastocyst-stage embryos [19] . hESCs hold great promise to become an unprecedented system for gaining insight into the molecular and cellular mechanisms that dictate lineage specification during early stages of human development. In addition, the most obvious advantages of hESCs are their pluripotency and immortality, which could potentially provide an unlimited stable supply of chondroprogenitor cells and differentiated chondrocytes for transplantation therapy.
Our group's prevailing research interests involve utilizing hESCs as a model system of analysis to understand the microenvironment, growth factors, and signaling pathways that direct and control early osteochondrogenic differentiation and commitment. Current studies in our laboratory have shown that BMP2 is able to induce chondrogenic differentiation and maturation/hypertrophy of human embryoid body (hEB)-derived cells in both 2-D EB monolayer and 3-D high-density micromass culture systems, of which a distinct temporal pattern of chondrogenic activation and hypertrophic development was observed. BMP2 induced an earlier and more robust chondrogenic activation and hypertophic development in highdensity micromass system, when compared to the monolayer system. This clearly demonstrated the importance of cell-to-cell contact, which makes the high-density micromass system a more appropriate system to study chondrogenesis (Toh, W.S. et al. submitted for publication). Notably, further analysis suggested that BMP2 exerts a bipotent effect in inducing both chondrogenic and osteogenic differentiation, while TGFβ1 played a stirring effect in driving chondrogenesis predominately, with inhibition of osteogenesis. Our results also indicate that TGFβ1 alone could be sufficient to promote chondrogenesis of hEB-derived cells, from chondrogenic activation to maturation to become hypertropic chondrocytes. Both factors revealed little synergistic cooperation in enhancing chondrogenic differentiation, although BMP2 promotes hypertrophic development in synergy with TGFβ1, a phenomenon that was not observed in BM-MSCs [17] . This finding is consistent with previous studies on human embryonic germ cells [20] and mouse embryonic stem cells [21] which showed that a combination of BMP and TGFβ does not have a cooperative effect in enhancing chondrogenic differentiation.On the other hand, it was well-documented in several studies [22, 23] that different isoforms of BMPs, such as BMP2 and BMP6, interact in a synergistic fashion with TGFβ in the enhancement of chondrogenic differentiation of hMSCs. These findings suggested the disparate effects of growth factors on stem cells of embryonic and adult origin during the course of development. It is also important to note in this context that ESCs represent a pluripotent cell source with the ability of differentiating into a far wider range of lineages compared to adult stem cells such as MSCs, which are committed primarily to mesenchymal cell lineages. Furthermore, one has to consider that EBs contain a variety of differentiated cell types and in a culture system whereby hEB-derived cells were induced into the chondrogenic lineage by specific growth factors, the interaction among different lineages and how each may affect another during the course of development remains to be elucidated.
Eventual application of hESCs in cell-based cartilage regeneration will depend largely on our ability to differentiate hESCs specifically into a specific lineage of interest, followed by purification of the desired cell population. Molecular and genetic manipulation (gain-and loss-of-function) on signaling transduction pathways implicated in chondrogenesis will have to be explored. Purification of lineagespecific subpopulations of interest from the bulk population of differentiating hESCs and hEBs represents another critical step for any potential gene and cell therapy strategies. This could be achieved by the introduction of reporter/selector genes, which are rigidly expressed under the control of lineage-specific promoters to track the lineage commitment of hESCs [24] . Looking to the future, generation of chondrogenic-specific collagen II-promoter-driven green fluorescence protein expression system in hESCs may be a promising and feasible strategy for identification and selection of putative chondroprogenitors and chondrocytes at different stages of differentiation for further characterization and eventual clinical application.
